RetaMaps

Aram E. Jawed MD FACS FASMBS

Aram E. Jawed MD FACS FASMBS · 1 Wellbrook Place, Suite 3-1 · Edison, NJ 08820

5.0· 152 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Aram E. Jawed, MD FACS FASMBS, is a physician in Edison, New Jersey whose listing shows weight-loss care. The website attached to this listing is a Hackensack Meridian Health provider directory rather than a practice page, so no further details are available. On Google it has a 5.0-star rating across 152 reviews dating back to 2022, with 32 in the past year. Reviewers most often mention the providers' knowledge and the staff, with 21 mentioning results and 18 feeling cared for.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay acceptedYes
Accepts insurance — per practice websiteNot listed
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 152 reviews
32
reviews in the past year (avg ★ 5.0)
15
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-16. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 152 Google reviews. Of the 100 reviews we analyzed, 99 (99%) are positive (4–5★) and 1 (1%) are negative (1–2★).

What patients like

  • Friendly, helpful staff22 reviews
  • Weight-loss results21 reviews
  • Knowledgeable, professional providers20 reviews
  • Feeling listened to18 reviews

Common complaints

Very few complaints — only 1 negative review, with no recurring theme.

5★
99
4★
0
3★
0
2★
0
1★
1

Most recent Google reviews

Jonathan M.★★★★★2026-09-16

Thank God, Doctor Jawa had operated me. It was a pleasure of him doing the Bariatric surgeon of operation and he had very good hands and his team was also professional and you know I would always go back to the doctor if I have to get any surgery or operation to cut my fat off?

Amanda F.★★★★★2026-09-10

I just got a call from Hackensack Meridian that Dr. Jawed is not longer associated with that practice. Does anyone know where he has moved the practice to? I really like Dr. Jawed and do not want to switch to another doctor.

Michelle C.★★★★★2026-07-22

Dr Jawed has truly changed my life , he was patient and helped me through my surgery and helped me gain confidence I needed

Alisson T.★★★★★2026-07-09

January 2026 I underwent a gastric sleeve procedure with Dr. Jawed and I’ve loss 45 lbs so far. I couldn’t be happier with the care I received. From the initial consultation through recovery, Dr. Jawed along with his amazing staff explained every step clearly, answered all my questions, and made sure I felt supported throughout the process. The surgery went smoothly, and my recovery has been steady thanks to excellent post-operative guidance and follow-up. I’m grateful for Dr. Jawed expertise, professionalism, and compassionate approach. I would highly recommend Dr. Jawed to anyone considering gastric sleeve surgery. Thank you so much Dr Jawed 🙌

Octavia M.★★★★★2026-07-02

I recommend him he is awesome I lost over 60 pounds after surgery use him he’s great

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Aram E. Jawed MD FACS FASMBS

Nearby providers in Edison

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs